2021. Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland – the SAKK 95/16 prostate study. Swiss Medical Weekly. 151, 0910 (Mar. 2021), w20464. DOI:https://doi.org/10.4414/smw.2021.20464.